FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 01:13:40 14/05/2024 am IST | ||
| 0.19 EUR | +5.56% |
|
| Current month | -52.63% | ||
| 1 month | -58.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 0.19 | +5.56% | 0 |
| 10/24/10 | 0.18 | 0.00% | 0 |
| 09/24/09 | 0.18 | -10.00% | 0 |
| 08/24/08 | 0.2 | -4.76% | 0 |
| 07/24/07 | 0.21 | 0.00% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 14, 2024 at 01:13 am IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0QX6 |
| ISIN | DE000SB0QX65 |
| Date issued | 04/06/2020 |
| Strike | 223.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.01 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.68 € |
|---|---|
| Lowest since issue | 0.17 € |
| Spread | 0.01 € |
| Spread % | 5.00% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat